Guidance adherent dabigatran etexilate treatment versus warfarin in the RE-LY population: an analysis on the basis of the European label recommendations for dabigatran etexilate
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- August 1, 2013
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- European Heart Journal Journal